morpholinoanthracycline mx2 has been researched along with HIV Coinfection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukue, H; Fukutake, K; Gohchi, K; Ishigatsubo, Y; Kimura, S; Koitabashi, Y; Matsuda, J; Okubo, T; Shimada, K; Yamada, K | 1 |
1 trial(s) available for morpholinoanthracycline mx2 and HIV Coinfection
| Article | Year |
|---|---|
[Phase III clinical trial of KRN8601 (rhG-CSF) for neutropenia in patients with human immunodeficiency virus infection].
Topics: Adolescent; Adult; Carubicin; Female; HIV Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia | 1994 |